Intelligence Β· Clinical Pipeline

NORTHWEST BIOTHERAPEUTICS Pipeline

All ClinicalTrials.gov programs at NORTHWEST BIOTHERAPEUTICS β€” phase, modality, and trial IDs.

Programs
8

Quick answer

NORTHWEST BIOTHERAPEUTICS has 8 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. DCVac-L

    NORTHWEST BIOTHERAPEUTICS INC

    Ovarian Cancer

    phase 1 mab completed

    1 trial
  2. DCVax-Direct

    NORTHWEST BIOTHERAPEUTICS INC

    Brain Metastases

    phase 1 mab active

    1 trial
  3. Gonadotrophin releasing hormone agonist(GnRHa)

    NORTHWEST BIOTHERAPEUTICS INC

    GnRHa;LPS

    phase 1 small molecule active

    1 trial
  4. Menopur 150 international units

    NORTHWEST BIOTHERAPEUTICS INC

    Pregnancy

    phase 1 small molecule terminated

    1 trial
  5. Omega-3 fatty acids

    NORTHWEST BIOTHERAPEUTICS INC

    Metabolic Syndrome X

    phase 1 other active

    1 trial
  6. Xanthohumol

    NORTHWEST BIOTHERAPEUTICS INC

    Healthy

    phase 1 small molecule active

    1 trial
  7. [14C]-benzo[a]pyrene

    NORTHWEST BIOTHERAPEUTICS INC

    Environmental Exposure

    phase 1 small molecule completed

    3 trials
  8. interceptive orthodontic treatments

    NORTHWEST BIOTHERAPEUTICS INC

    Malocclusion

    phase 1 other active

    1 trial

Frequently asked questions

How many pipeline programs does NORTHWEST BIOTHERAPEUTICS have?

8 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources Β· All pipeline programs